Select Medical Q4 Revenue Jumps 8% to $1.78B, EBITDA Up 10%
Select Medical reported fourth‐quarter revenue of $1.78 billion, an 8% increase year‐over‐year, and adjusted EBITDA of $260 million, up 10%. Management raised 2025 revenue guidance to $7.3 billion and projected a 200-basis-point expansion in adjusted EBITDA margins.
1. Fourth-Quarter Financial Results
Select Medical posted Q4 revenue of $1.78 billion, up 8% year-over-year, driven by a 9% rise in inpatient admissions and a 5% increase in outpatient services. Adjusted EBITDA reached $260 million, representing a 10% gain, as cost controls and operational efficiencies improved across the network.
2. 2025 Guidance and Outlook
Management raised full‐year 2025 revenue guidance to $7.3 billion, up from prior estimates of $7.1 billion, and expects adjusted EBITDA margins to expand by 200 basis points. The forecast reflects continued volume growth, synergies from recent acquisitions, and targeted cost-reduction initiatives.